![]()
|
|
||||||||
J Biol Chem, Vol. 273, Issue 19, 11483-11490, May 8, 1998
,
,
,
**
From the Previous studies have suggested that PECAM-1
mediates cellular interactions via both homophilic and heterophilic
adhesive mechanisms. Cell surface glycoaminoglycans have been
implicated as one of the heterophilic ligands for PECAM-1. To determine
whether PECAM-1 is capable of interacting directly with
glycosaminoglycans, we examined the adhesive properties of multiple
monovalent and multivalent forms of this adhesion molecule. We found
that the binding of a bivalent PECAM-1/IgG chimeric protein or
multivalent PECAM-1-containing proteoliposomes to multiple different
cell lines was 1) strictly dependent upon cell surface expression of PECAM-1 and 2) unaffected by the presence of excess heparin or heparan
sulfate. The extracellular domain of PECAM-1 failed to interact
specifically with heparin-Sepharose, 3H-labeled
heparin, or a heparin-bovine serum albumin conjugate. In addition, an
amino acid sequence motif inadvertently created by the juxtaposition of
PECAM-1 and IgG sequences within the hinge region of certain
PECAM-1/IgG chimeric constructs was found to confer glycosaminoglycan
binding properties not normally present within the extracellular domain
of the native molecule. Together, these data suggest that the mechanism
by which heparin is able to affect PECAM-1-dependent
cell-cell adhesion is indirect and occurs via inhibition of events that
occur downstream from PECAM-1 engagement.
Blood Research Institute, The Blood Center
of Southeastern Wisconsin, Milwaukee, Wisconsin 53233-2194, § Amgen Boulder, Inc., Boulder, Colorado 80301, the
** Departments of Cellular Biology and Pharmacology, The Medical College
of Wisconsin, Milwaukee, Wisconsin 53226, and the ¶ Department of
Pathology, Cornell University Medical College,
New York, New York 10021
This article has been cited by other articles:
![]() |
U. J. H. Sachs, C. L. Andrei-Selmer, A. Maniar, T. Weiss, C. Paddock, V. V. Orlova, E. Y. Choi, P. J. Newman, K. T. Preissner, T. Chavakis, et al. The Neutrophil-specific Antigen CD177 Is a Counter-receptor for Platelet Endothelial Cell Adhesion Molecule-1 (CD31) J. Biol. Chem., August 10, 2007; 282(32): 23603 - 23612. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. S. Warren, A. L. Jones, C. Freeman, J. Bettadapura, and C. R. Parish Evidence That the Cellular Ligand for the Human NK Cell Activation Receptor NKp30 Is Not a Heparan Sulfate Glycosaminoglycan J. Immunol., July 1, 2005; 175(1): 207 - 212. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. D. O'Brien, G. Cao, A. Makrigiannakis, and H. M. DeLisser Role of immunoreceptor tyrosine-based inhibitory motifs of PECAM-1 in PECAM-1-dependent cell migration Am J Physiol Cell Physiol, October 1, 2004; 287(4): C1103 - C1113. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. T. Nakada, K. Amin, M. Christofidou-Solomidou, C. D. O'Brien, J. Sun, I. Gurubhagavatula, G. A. Heavner, A. H. Taylor, C. Paddock, Q.-H. Sun, et al. Antibodies Against the First Ig-Like Domain of Human Platelet Endothelial Cell Adhesion Molecule-1 (PECAM-1) That Inhibit PECAM-1-Dependent Homophilic Adhesion Block In Vivo Neutrophil Recruitment J. Immunol., January 1, 2000; 164(1): 452 - 462. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Oleszewski, S. Beer, S. Katich, C. Geiger, Y. Zeller, U. Rauch, and P. Altevogt Integrin and Neurocan Binding to L1 Involves Distinct Ig Domains J. Biol. Chem., August 27, 1999; 274(35): 24602 - 24610. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Cao, C. D. O'Brien, Z. Zhou, S. M. Sanders, J. N. Greenbaum, A. Makrigiannakis, and H. M. DeLisser Involvement of human PECAM-1 in angiogenesis and in vitro endothelial cell migration Am J Physiol Cell Physiol, May 1, 2002; 282(5): C1181 - C1190. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |